Showing results (91-100 of 305) with videos related to

Sort By:
Pageof 31
European Journal of Haematology|September 30, 2005
Thalidomide plus dexamethasone is an effective salvage regimen for myeloma patients relapsing after autologous transplantAntonio Palumbo, Patrizia Falco, Maria Teresa Ambrosini, et al.
Cancer|April 22, 2011
The efficacy and safety of bortezomib and dexamethasone as a maintenance therapy in patients with advanced multiple myeloma who are responsive to salvage bortezomib-containing regimensGiulia Benevolo, Alessandra Larocca, Massimo Gentile, et al.
Haematologica|June 29, 2014
The bone marrow of myeloma patients is steadily inhabited by a normal-sized pool of functional regulatory T cells irrespectiveof the disease statusMyriam Foglietta, Barbara Castella, Sara Mariani, et al.
ISRN Oncology|March 28, 2013
Decreasing frequency of osteonecrosis of the jaw in cancer and myeloma patients treated with bisphosphonates: the experience of the oncology network of piedmont and aosta valley (north-Western Italy)Vittorio Fusco, Claudia Galassi, Alfredo Berruti, et al.
European Journal of Haematology|May 19, 2010
Lenalidomide plus dexamethasone vs. lenalidomide plus melphalan and prednisone: a retrospective study in newly diagnosed elderly myelomaFrancesca Gay, S Vincent Rajkumar, Patrizia Falco, et al.
Annals of Hematology|April 8, 2014
Survival improvement of poor-prognosis AML/MDS patients by maintenance treatment with low-dose chemotherapy and differentiating agentsDario Ferrero, Elena Crisà, Filippo Marmont, et al.
Eclinicalmedicine|January 22, 2026
Temporal trends in progression risk in smoldering myeloma: a systematic reviewHeinz Ludwig, Efstathios Kastritis, Sarah Bernhard, et al.
Cytometry. Part B, Clinical Cytometry|August 20, 2015
Multiple myeloma: New surface antigens for the characterization of plasma cells in the era of novel agentsVittorio Emanuele Muccio, Elona Saraci, Milena Gilestro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2009
Preclinical studies in support of defibrotide for the treatment of multiple myeloma and other neoplasiasConstantine S Mitsiades, Cecile Rouleau, Cinara Echart, et al.
Cancer|August 7, 2008
A multicenter, randomized clinical trial comparing zoledronic acid versus observation in patients with asymptomatic myelomaPellegrino Musto, Maria Teresa Petrucci, Sara Bringhen, et al.
Pageof 31